|
CHMP5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10200737424293E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43490000384483E-08 |
| Normal-vs-Stage2 |
8.993400E-04 |
| Normal-vs-Stage3 |
7.32747196252603E-15 |
| Normal-vs-Stage4 |
1.63180580159406E-12 |
| Stage1-vs-Stage2 |
6.457800E-01 |
| Stage1-vs-Stage3 |
1.16019999996109E-06 |
| Stage1-vs-Stage4 |
3.81890000000773E-06 |
| Stage2-vs-Stage3 |
7.008400E-04 |
| Stage2-vs-Stage4 |
1.139190E-03 |
| Stage3-vs-Stage4 |
8.493000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.95650179285667E-12 |
| Normal-vs-AfricanAmerican |
4.0415000013283E-08 |
| Normal-vs-Asian |
1.744570E-01 |
| Caucasian-vs-AfricanAmerican |
9.572400E-01 |
| Caucasian-vs-Asian |
2.503200E-01 |
| AfricanAmerican-vs-Asian |
2.114600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.76143560743003E-13 |
| Normal-vs-Female |
7.99309995969111E-09 |
| Male-vs-Female |
5.136300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.08990000048071E-07 |
| Normal-vs-Age(41-60Yrs) |
2.56779997265255E-09 |
| Normal-vs-Age(61-80Yrs) |
2.59636756538839E-12 |
| Normal-vs-Age(81-100Yrs) |
1.206960E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.499800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.280200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.331000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.907390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.296200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.648000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.056800E-01 |
| Normal-vs-Grade 2 |
4.94869999978498E-07 |
| Normal-vs-Grade 3 |
1.62481139653892E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
2.274400E-01 |
| Grade 1-vs-Grade 3 |
3.219200E-03 |
| Grade 1-vs-Grade 4 |
7.87870000000801E-05 |
| Grade 2-vs-Grade 3 |
2.23249999999897E-05 |
| Grade 2-vs-Grade 4 |
3.82039999635708E-09 |
| Grade 3-vs-Grade 4 |
1.156280E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.359300E-04 |
| Normal-vs-ccB subtype |
1.62625468647093E-12 |
| ccA subtype-vs-ccB subtype |
1.84685600146395E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.39040001734259E-09 |
| Normal-vs-N1 |
7.65819999970496E-07 |
| N0-vs-N1 |
9.823900E-02 |
|
|
